Related Experiment Video

Updated: Feb 27, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.9K

Chagas disease

José A Pérez-Molina1, Israel Molina2

  • 1National Referral Centre for Tropical Diseases, Infectious Diseases Department, Hospital Universitario Ramón y Cajal, Insituto Ramón y Cajal de Investgación Sanitaria, Madrid, Spain.

Lancet (London, England)
|July 5, 2017
PubMed

Insights

Chagas disease, caused by Trypanosoma cruzi, remains a significant health challenge in the Americas. Improved diagnostics, treatments, and control strategies are crucial for managing this complex parasitic infection.

Area of Science:

  • Neglected tropical diseases
  • Parasitic infections
  • American trypanosomiasis

Background:

  • Chagas disease is a zoonotic parasitic disease endemic to the Americas, caused by Trypanosoma cruzi.
  • Migration has led to the global spread of Chagas disease.
  • Chronic Chagas disease can lead to severe complications like cardiomyopathy and megaviscera in 30-40% of cases.

Purpose of the Study:

  • To highlight the persistent challenges in Chagas disease management.
  • To emphasize the need for advancements in control, diagnosis, and therapy.
  • To underscore the evolving patient population and their complex needs.

Main Methods:

  • Review of current knowledge and challenges in Chagas disease.
  • Analysis of limitations in existing diagnostic, therapeutic, and prognostic tools.
  • Discussion of the changing epidemiological landscape and patient demographics.

Main Results:

  • Despite over a century of study, significant unmet needs persist in Chagas disease control and treatment.
  • Current therapeutic agents have suboptimal efficacy and tolerability.
  • The affected population is increasingly complex, including elderly and immunocompromised individuals.

Conclusions:

  • Substantial improvements in epidemiological control, diagnostics, therapeutics, and prognostics are urgently required.
  • Addressing the limitations of current treatments is critical for improving patient outcomes.
  • Enhanced international collaboration and research are essential to combat Chagas disease effectively in the 21st century.

More Related Videos

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.2K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.7K

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.3K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
668
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
37.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K